News

The acquisition includes assignment of certain patents and patent applications owned or controlled by the Swiss firm related to RNAi therapeutics. The deal also comprises of an exclusive

According to the company, the barcode on the overwrap is correct but the primary container barcode could be mislabeled with the barcode for Heparin Sodium 2000 USP units/1000mL

The two angiotensin-converting enzyme (ACE) inhibitors are approved by Health Canada and they will now be commercialized and manufactured locally by Valeant at its Laval, Quebec facility. Population

Under the deal, BMS will have an exclusive option to license and commercialize Prostvac, which is being developed to treat asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer

Imbruvica is approved for use in four indications to treat three different types of blood cancers including chronic lymphocytic leukemia, mantle cell lymphoma and Waldenstrom’s macroglobulinemia. AbbVie chairman

The BLA is based on results from the LEOPOLD clinical trials, which evaluated BAY 81-8973 in adults and children using two- and three-times-per-week prophylaxis dosing regimens. The trials,

The company said that the label has also been updated to include efficacy data from Pfizer’s Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). The CAPiTA trial showed statistically

The deal will see evaluation of the safety, tolerability and efficacy of Merck’s anti-PD-1 therapy, pembrolizumab (KEYTRUDA in US), in combination with Eisai oncology compounds lenvatinib mesylate (Lenvima)

The company said that Opdivo is the first and only programed death receptor-1 (PD-1) therapy to show overall survival in previously treated metastatic squamous NSCLC. The approval is